Antimicrobial Susceptibility Testing Market Size, Share, Trends, Growth Outlook

Antimicrobial Susceptibility Testing Market is estimated to increase at a Compounded Annual Growth Rate of 6.3% CAGR over the forecast period from 2024 to 2030

The Antimicrobial Susceptibility Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Manual, Automated Laboratory Instruments, Culture and Growth Media, Consumables), By Type (Antibacterial, Antifungal, Antiparasitic, Others), By Method (ETEST, Disk Diffusion, Automated Susceptibility testing instruments, Agar Diffusion, Genotyping), By Application (Clinical Diagnostics, Drug Discovery and development, Epidemiology, Others), By End-User (Hospitals and Diagnostic centers, Pharmaceutical and Biotechnology Companies, Research &Academic Institutes, Clinical Research Organizations).

An Introduction to Antimicrobial Susceptibility Testing Market in 2024

Antimicrobial susceptibility testing is a cornerstone of infectious disease management, providing critical information to guide antibiotic selection, dose optimization, and treatment duration for bacterial infections. In 2024, susceptibility testing methodologies encompass a variety of techniques, including broth microdilution, disk diffusion, and automated systems, designed to assess the in vitro activity of antimicrobial agents against bacterial isolates. These tests help clinicians determine the most appropriate antibiotic therapy for individual patients, taking into account factors such as microbial susceptibility patterns, pharmacokinetics, and patient-specific factors. With advancements in molecular diagnostics and informatics, antimicrobial susceptibility testing continues to evolve, offering rapid, accurate, and comprehensive results to support clinical decision-making and antimicrobial stewardship efforts. As antimicrobial resistance remains a global health threat, susceptibility testing remains essential in guiding empiric therapy, optimizing treatment outcomes, and combating the spread of multidrug-resistant pathogens in healthcare settings.

Market Trend: Adoption of Rapid Molecular Testing Methods

One prominent trend in the antimicrobial susceptibility testing market is the adoption of rapid molecular testing methods. Traditional antimicrobial susceptibility testing (AST) methods, such as culture-based techniques, can be time-consuming and labor-intensive, delaying the initiation of appropriate antibiotic therapy. In response, there is a growing shift towards molecular-based AST methods that offer faster turnaround times and greater accuracy in detecting antimicrobial resistance mechanisms. Molecular testing platforms utilize nucleic acid amplification and detection technologies to rapidly identify specific genetic markers associated with antibiotic resistance, enabling timely and targeted antimicrobial therapy decisions. This trend reflects the increasing demand for rapid diagnostic solutions to combat antimicrobial resistance and improve patient outcomes in clinical settings.

Market Driver: Escalating Threat of Antimicrobial Resistance

A significant driver in the antimicrobial susceptibility testing market is the escalating threat of antimicrobial resistance (AMR). The emergence and spread of multidrug-resistant bacteria pose significant challenges to healthcare systems worldwide, leading to treatment failures, increased healthcare costs, and higher morbidity and mortality rates. Antimicrobial susceptibility testing plays a crucial role in guiding antibiotic selection and treatment strategies by providing clinicians with essential information about the susceptibility profile of bacterial pathogens. The growing prevalence of antimicrobial resistance drives the demand for accurate and timely AST methods that can identify resistant bacteria and inform appropriate antibiotic therapy decisions, driving market growth and innovation in AST technologies.

Market Opportunity: Development of Point-of-Care Testing Solutions

An emerging opportunity in the antimicrobial susceptibility testing market is the development of point-of-care testing solutions. Point-of-care AST technologies enable rapid on-site testing of bacterial isolates directly from patient specimens, allowing clinicians to obtain actionable susceptibility results within minutes at the bedside or in outpatient settings. By providing near real-time information on antibiotic resistance patterns, point-of-care AST solutions empower clinicians to make informed treatment decisions, optimize antibiotic prescribing practices, and improve patient outcomes. This presents an opportunity for technology developers, diagnostic companies, and healthcare providers to collaborate on developing user-friendly, cost-effective, and rapid point-of-care AST platforms that address the unmet need for timely antimicrobial susceptibility testing in diverse clinical settings. By capitalizing on the demand for point-of-care testing solutions, stakeholders in the antimicrobial susceptibility testing market can enhance patient care, reduce the spread of antimicrobial resistance, and contribute to the global effort to combat AMR.

Antimicrobial Susceptibility Testing Market Share Analysis: Automated Laboratory Instruments is the fastest growing segment over the forecast period to 2030

Among the segments in the Antimicrobial Susceptibility Testing Market, the Automated Laboratory Instruments segment is experiencing the fastest growth. This growth can be attributed to several factors driving the demand for automated instruments for antimicrobial susceptibility testing (AST). Firstly, there's a growing need for rapid and accurate AST results in clinical diagnostics to guide appropriate antimicrobial therapy and combat antimicrobial resistance. Automated laboratory instruments offer advantages such as high throughput, standardized testing protocols, and reduced turnaround times compared to manual methods, thereby improving laboratory efficiency and patient care outcomes. Additionally, advancements in automation technologies, including robotics, liquid handling systems, and integrated data management software, enhance the precision, reproducibility, and scalability of AST procedures, further driving the adoption of automated laboratory instruments. Furthermore, the increasing prevalence of multidrug-resistant pathogens and healthcare-associated infections underscores the importance of comprehensive AST capabilities in hospitals, diagnostic centers, and healthcare facilities worldwide. As healthcare providers and laboratories prioritize investments in advanced diagnostic technologies to address antimicrobial resistance challenges and improve patient outcomes, the Automated Laboratory Instruments segment is expected to sustain its rapid growth trajectory in the Antimicrobial Susceptibility Testing Market.

Antimicrobial Susceptibility Testing Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAccelerate Diagnostics Inc, Alifax S.r.l., Becton, Dickinson and Company, Bioanalyse GmbH, bioMérieux SA, Bio-Rad Laboratories Inc, Bruker Corp, Creative Diagnostics, Danaher Corp, F. Hoffmann-La Roche Ltd, HiMedia Laboratories Pvt. Ltd, Liofilchem S.r.l., Merck KGaA, Synbiosis, Thermo Fisher Scientific Inc

Antimicrobial Susceptibility Testing Market Segmentation

By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Antimicrobial Susceptibility Testing Market Companies

Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
Bruker Corp
Creative Diagnostics
Danaher Corp
F. Hoffmann-La Roche Ltd
HiMedia Laboratories Pvt. Ltd
Liofilchem S.r.l.
Merck KGaA
Synbiosis
Thermo Fisher Scientific Inc

Reasons to Buy the Antimicrobial Susceptibility Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Antimicrobial Susceptibility Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Antimicrobial Susceptibility Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Antimicrobial Susceptibility Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Antimicrobial Susceptibility Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Antimicrobial Susceptibility Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Antimicrobial Susceptibility Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Antimicrobial Susceptibility Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Antimicrobial Susceptibility Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Antimicrobial Susceptibility Testing Industry
4.2 Key Market Trends in Antimicrobial Susceptibility Testing Industry
4.3 Potential Opportunities in Antimicrobial Susceptibility Testing Industry
4.4 Key Challenges in Antimicrobial Susceptibility Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Antimicrobial Susceptibility Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Antimicrobial Susceptibility Testing Market Outlook by Segments
7.1 Antimicrobial Susceptibility Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations

8 North America Antimicrobial Susceptibility Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Antimicrobial Susceptibility Testing Markets in 2024
8.2 North America Antimicrobial Susceptibility Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Antimicrobial Susceptibility Testing Market size Outlook by Segments, 2021-2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations

9 Europe Antimicrobial Susceptibility Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Antimicrobial Susceptibility Testing Markets in 2024
9.2 Europe Antimicrobial Susceptibility Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Antimicrobial Susceptibility Testing Market Size Outlook by Segments, 2021-2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations

10 Asia Pacific Antimicrobial Susceptibility Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Antimicrobial Susceptibility Testing Markets in 2024
10.2 Asia Pacific Antimicrobial Susceptibility Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Antimicrobial Susceptibility Testing Market size Outlook by Segments, 2021-2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations

11 South America Antimicrobial Susceptibility Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Antimicrobial Susceptibility Testing Markets in 2024
11.2 South America Antimicrobial Susceptibility Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Antimicrobial Susceptibility Testing Market size Outlook by Segments, 2021-2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations
12 Middle East and Africa Antimicrobial Susceptibility Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Antimicrobial Susceptibility Testing Markets in 2024
12.2 Middle East and Africa Antimicrobial Susceptibility Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Antimicrobial Susceptibility Testing Market size Outlook by Segments, 2021-2030
By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
Bruker Corp
Creative Diagnostics
Danaher Corp
F. Hoffmann-La Roche Ltd
HiMedia Laboratories Pvt. Ltd
Liofilchem S.r.l.
Merck KGaA
Synbiosis
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Manual
-Susceptibility Testing Disks
-Mic Strips
-Susceptibility Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
By Type
Antibacterial
Antifungal
Antiparasitic
Others
By Method
ETEST
Disk Diffusion
Automated Susceptibility testing instruments
Agar Diffusion
Genotyping
By Application
Clinical Diagnostics
Drug Discovery and development
Epidemiology
Others
By End-User
Hospitals and Diagnostic centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)